Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin in Dilated Cardiomyopathy
NCT03775070Phase 2Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Jan 2019
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of simvastatin in dilated cardiomyopathy (DCM), sponsored by National Taiwan University Hospital. Primary endpoints: Left Ventricular Ejection Fraction at 24 months, Left Ventricular End-Diastolic Dimension at 24 months and 1 more. Started Jan 2019; status: completed.
02
Drugs
simvastatin
03
Conditions
dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT03775070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03775070.